Blood Test for Mesothelioma

Serum  Soluble Mesothelin-Related Peptides (SMRP) measurements may have a useful role in the diagnosis of mesothelioma and in monitoring disease progression.    SMRP is produced by mesothelioma cells, which may be elevated in the serum of patients of mesothelioma. The detection of SMRP through blood test helps to attain the early diagnosis of the disease which results in better treatment options and prognosis. 

 Mesomark Test  is easily done through blood tests that use enzyme-linked immunosorbent to measure the content of Soluble Mesothelin-Related Peptides (SMRP). The laboratory determines the amount of SMRP present in the blood by using monoclonal antibodies known to specifically bind to SMRP. By measuring the amount of bound antibodies, the laboratory can calculate the amount of SMRP present in the patient's blood.  
Elevated levels of SMRP are found in the serum of mesothelioma patients. 
 

 Physicians use the MESOMARK test results in making decisions about the management of patients with mesothelioma. Increasing results may be indicative of progressive disease conditions; decreasing or constant results may be indicative of response to therapy, or stable disease.